| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.9M | +17.2% |
| Cost of Revenue | $302K | +81.2% |
| Gross Profit | $1.6M | +9.7% |
| R&D Expense | $10K | -35.0% |
| SG&A Expense | $1.5M | +7.4% |
| Operating Income | $34K | +470.7% |
| Interest Expense | $13K | — |
| Pre-tax Income | -$70K | +34.4% |
| Net Income | -$72K | +32.4% |
| EPS (Basic) | -$0.01 | +0.0% |
| EPS (Diluted) | -$0.01 | +0.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $87K | -17.7% |
| Accounts Receivable | $219K | -10.8% |
| Inventory | $159K | -28.3% |
| Current Assets | $563K | -19.0% |
| Total Assets | $830K | -16.8% |
| Current Liabilities | $4.8M | +6.3% |
| Total Liabilities | $4.9M | +4.9% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$13K | -122.4% |
| Capital Expenditures | $5K | +24.4% |
| Investing Cash Flow | -$4K | -4.4% |
| Financing Cash Flow | -$812 | +89.3% |
| Free Cash Flow | -$19K | -133.4% |
| -$4.1M |
| -10.8% |